Therapeutic Strategies in Huntington's Disease: From Genetic Defect to Gene Therapy

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Huntington's disease (HD) is caused by an expanded CAG repeat in the huntingtin gene.
• Current therapies offer only symptomatic relief and do not alter disease progression.
• Numerous pathogenic mechanisms leading to neuronal degeneration have been identified, but therapeutic interventions have largely failed.

Purpose of the Study:

• To review emerging therapeutic strategies for Huntington's disease.
• To highlight the potential of gene editing, stem cell therapy, and targeted cascade interventions.

Main Methods:

• Review of emerging gene editing techniques targeting mutant huntingtin DNA and RNA.
• Discussion of stem cell therapies for neurodegenerative conditions.
• Analysis of traditional approaches targeting excitotoxicity and neurotrophic factor bioavailability.

Main Results:

• Gene editing presents novel opportunities for directly targeting the genetic cause of HD.
• Stem cell therapies and refined traditional methods show promise for neuronal repair and protection.
• Challenges such as off-target effects and immune responses require further research for gene editing strategies.

Conclusions:

• Emerging gene editing technologies offer a promising avenue for treating Huntington's disease at its genetic source.
• A combination of gene editing, stem cell therapy, and targeted cascade interventions could significantly improve patient outcomes.
• Addressing safety concerns is crucial for the successful clinical translation of these advanced therapeutic strategies.